Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasuda, K.
Right arrow Articles by Kitano, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, K.
Right arrow Articles by Kitano, S.
Related Collections
Right arrow Pathology
Right arrow Prognostic factors
Annals of Surgical Oncology 9:771-774 (2002)
© 2002 Society of Surgical Oncology

ORIGINAL ARTICLES

Prognostic Effect of Lymph Node Micrometastasis in Patients With Histologically Node-Negative Gastric Cancer

Kazuhiro Yasuda, MD, Yosuke Adachi, MD, Norio Shiraishi, MD, Masafumi Inomata, MD, Hiroaki Takeuchi, MD and Seigo Kitano, MD, FACS

From the Department of Surgery I, Oita Medical University, Oita, Japan.

Correspondence: Address correspondence and reprint requests to: Kazuhiro Yasuda, MD, Department of Surgery I, Oita Medical University, 1-1 Idaigaoka, Hasama-machi, Oita 879-5593, Japan; Fax: 81-97-549-6039; E-mail: kyasuda{at}oita-med.ac.jp

Background: There is no consensus as to the impact of lymph node micrometastasis on survival of patients with gastric cancer. The aim of this study was to clarify the prognostic significance of lymph node micrometastasis in patients with histologically node-negative gastric cancer.

Methods: Lymph nodes (n = 2039) from 64 patients with histologically node-negative gastric cancer (T2, T3) were evaluated for micrometastasis. Three serial 5-µm sections of the resected lymph nodes were prepared for immunohistochemical staining with the anti-cytokeratin antibody CAM 5.2.

Results: Micrometastasis was found in 73 of 2039 nodes (4%) and 20 of 64 patients (32%). The 5-year survival rate was significantly lower for patients with lymph node micrometastasis than for those without lymph node micrometastasis (66% vs. 95%, P < .01). The 5-year survival rate was significantly lower when there were four or more positive micrometastatic nodes (94% vs. 29%, P < .01) and when there were extragastric micrometastatic nodes (89% vs. 53%, P < .01).

Conclusions: Lymph node micrometastasis was associated with poor outcome in patients with histologically node-negative gastric cancer. The number and the level of lymph node micrometastases are useful prognostic markers for deciding treatment strategies for additional therapy and follow-up.

Key Words: Gastric cancer • Lymph node micrometastasis • Immunohistochemistry • Cytokeratin • Prognosis




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
S. McGrath, S. Cross, and S. A. Pritchard
Histopathological assessment of lymph nodes in upper gastrointestinal cancer: does triple levelling detect significantly more metastases?
J. Clin. Pathol., November 1, 2007; 60(11): 1222 - 1225.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Gretschel, A. Bembenek, M. Hunerbein, S. Dresel, W. Schneider, and P. M. Schlag
Efficacy of Different Technical Procedures for Sentinel Lymph Node Biopsy in Gastric Cancer Staging
Ann. Surg. Oncol., July 1, 2007; 14(7): 2028 - 2035.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society of Surgical Oncology.